Page 1 of 1INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.1. Company Name and Address4. EPA ProductRegistrationOMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460DATA CALL-IN RESPONSE3. Date and Type of DCI and NumberGENERIC17-Mar-2010ID # GDCI-035602-290242. Case # and Name2135 Dazomet, and saltsChemical # and Name035602Dazomet5. I wish tocancel thisproduct registration voluntarily6. Generic Data7. Product Specific Data7a. My product is an MUP andI agree to satisfy the MUPrequirements on the attachedform entitled "RequirementsStatus and Registrant'sResponse."7b. My product is an EUP andI agree to satisfy the EUPrequirements on the attachedform entitled "RequirementsStatus and Registrant'sResponse."6a. I am claiming a GenericData Exemption because Iobtain the active ingredientfrom the source EPA registration number listed below.6b. I agree to satisfy GenericData requirements as indicatedon the attached form entitled"Requirements Status andRegistrant's Response."N.A.N.A.10. Name of Company11. Phone Number9. Date8. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that anyknowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law.Signature and Title of Company's Authorized Representative__________________________________DazometINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 1 of 3OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #GENERIC17-Mar-2010GDCI-035602-290242. Case # and Name2135 Dazomet, and salts035602Chemical # and Name8. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321Applicator Exposure Data Requirements (Antimicrobial)(7 ,8)875.120024BB, GG, Y, X, FF, ZDermal exposure--Indoor(9 ,10 ,11)875.140024BB, GG, Y, X, FF, ZInhalation exposure--indoor(12)875.160024BB, GG, Y, X, FF, ZApplication exposure monitoring data reporting(34 ,35)875.170024BB, GG, Y, X, FF, ZProduct Use InformationPost-Application Exposure Data Requirements (ConventionalChemical)(1 ,13 ,14)875.250024BB, GG, Y, X, FF, ZInhalation exposure(2)875.290024BB, GG, Y, X, FF, ZData reporting and calculationsPostapplication Exposure Data Requirements (Antimicrobial)(15)875.280024BB, GG, Y, X, FF, ZDescription of human activity(3)875.270024BB, GG, Y, X, FF, ZProduct Use InformationProduct Chemistry Data Requirements (Antimicrobial)12. Name of Company13. Phone NumberSignature and Title of Company's Authorized Representative__________________________________10. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. Iacknowledge that anyknowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law11. DateDazometINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 2 of 3OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #GENERIC17-Mar-2010GDCI-035602-290242. Case # and Name2135 Dazomet, and salts035602Chemical # and Name8. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(21)830.70508TGAI & DegrBB, GG, Y, X, FF, ZUV/Visible absorptionResidue Chemistry Data Requirements (Antimicrobial)(6)860.152024TEP & MetBB, GG, Y, X, FF, ZProcessed food/feed(FOOD COMMODITIES)Terrestrial and Aquatic Nontarget Organisms DataRequirements (Antimicrobial)(18)850.102512DEGRBB, GG, Y, X, FF, ZOyster acute toxicity test (shell deposition)(19)850.103512DEGRBB, GG, Y, X, FF, ZMysid acute toxicity test(16 ,17)850.107512DEGRBB, GG, Y, X, FF, ZFish acute toxicity test, freshwater and marineToxicology Data Requirements (Antimicrobial)(24 ,25)870.370024DEGRBB, GG, Y, X, FF, ZPrenatal developmental toxicity study(26 ,27 ,28)870.380048DEGRBB, GG, Y, X, FF, ZReproduction and fertility effects(32 ,33)870.420048DEGRBB, GG, Y, X, FF, ZCarcinogenicity(29 ,30 ,31)870.53958DEGRBB, GG, Y, X, FF, ZMammalian erythrocyte micronucleus testInitial to indicate certification as to information on this page (fulltext of certification is on page one).DateDazometINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 3 of 3OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #GENERIC17-Mar-2010GDCI-035602-290242. Case # and Name2135 Dazomet, and salts035602Chemical # and Name8. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(22 ,23)870.62008DEGRBB, GG, Y, X, FF, ZNeurotoxicity screening battery(20)870.780012DEGRBB, GG, Y, X, FF, ZImmunotoxicity(4 ,5)850.210012DEGRBB, GG, Y, X, FF, ZAvian acute oral toxicity testInitial to indicate certification as to information on this page (fulltext of certification is on page one).DateCase # and Name:2135 Dazomet, and saltsDCI Number:GDCI-035602-29024Page 1 of 3[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSTEP & Met = Typical End-Use Product and Metabolites; TGAI & Degr = Technical Grade of the Active Ingredient and Degration Product; DEGR = Degradant [DEGR]Use Categories Key:X -Y -Z -Materials preservativesIndustrial processes and watersIndustrial processes and watersBB -FF -GG -Wood preservativesHigh Exposure AntimicrobialLow Exposure Antimicrobial1Data required on MITC.2Post-application data reporting calculations are required on MITC.3Data are required describing how dazomet is actually used and applied, including information on post-application entry restrictions, re-entry intervals, rinsing and other residue removal practices,and other use data relevant to exposure after application.4Data are required on one passerine species and either one waterfowl species or one upland game bird species for terrestrial, aquatic, forestry, and residential outdoor uses. Data are preferredon waterfowl or upland game bird species for indoor and greenhouse uses.5Study required with MITC.6Confirmatory food contact paper residue data are required on dazomet and MITC in support of antimicrobial uses.7Biological monitoring data may be submitted in addition to, or in lieu of, dermal and inhalation exposure data, provided the human pharmocokinetics of the pesticide and/or metabolite/analogcompounds (i.e., whichever method is selected as an indicator of body burden or internal dose) allow for the back calculation to actual dose.8Protocols must be submitted for approval prior to the initiation of the study. Details for developing protocols are availablefrom the Agency.9Data required on dazomet.10Protocols must be submitted for approval prior to the initiation of the study. Details for developing protocols are availablefrom the Agency.11Biological monitoring data may be submitted in addition to, or in lieu of, dermal and inhalation exposure data, provided the human pharmocokinetics of the pesticide and/or metabolite/analogcompounds (i.e., whichever method is selected as an indicator of body burden or internal dose) allow for the back calculation to actual dose.12Data required on dazomet.13Protocols must be submitted for approval prior to the initiation of the study. Details for developing protocols are availablefrom the Agency.14Biological monitoring data may be submitted in addition to, or in lieu of, dermal and inhalation exposure data, provided the human pharmocokinetics of the pesticide and/or metabolite/analogcompounds (i.e., whichever method is selected as an indicator of body burden or internal dose) allow for the back calculation to actual dose.15Data on worker application parameters are required.Case # and Name:2135 Dazomet, and saltsDCI Number:GDCI-035602-29024Page 2 of 3[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSTEP & Met = Typical End-Use Product and Metabolites; TGAI & Degr = Technical Grade of the Active Ingredient and Degration Product; DEGR = Degradant [DEGR]16Study required only on estuarine/marine fish.17Study required with MITC.18Study required with MITC.19Study required with MITC.20Study required with MITC.21Study required with dazomet and MITC.22Acute neurotoxicity study required in rat via the inhalation route with pathological evaluation of the complete respiratory tract.23Study required with MITC.24Inhalation reproductive and developmental toxicity screening study in rats and rabbits is required.25Study required with MITC.26The use of a combined study that utilizes the 2-generation addition of other endpoints or functional assessments in the immature animal is encouraged.27Two generation reproduction study in rats via inhalation with gross and histopathological evaluation of the complete respiratory tract in offspring is required. The Agency would be open todiscussing with the registrant the potential for performing the new enhanced one-generation reproductive study instead of the standard two-generation study.28Study required with MITC.29The micronucleus rodent bone marrow assay is preferred; however, rodent bone marrow assays using metaphase analysis (aberrations) are acceptable.30At a minimum, an initial battery of mutagenicity tests with possible confirmatory testing is required. Other relevant mutagenicity tests that may have been performed, plus a complete referencelist must also be submitted.Case # and Name:2135 Dazomet, and saltsDCI Number:GDCI-035602-29024Page 3 of 3[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSTEP & Met = Typical End-Use Product and Metabolites; TGAI & Degr = Technical Grade of the Active Ingredient and Degration Product; DEGR = Degradant [DEGR]31Study required with MITC.32Chronic inhalation carcinogenicity and toxicity studies in rats and mice is required.33Study required with MITC.34Data required to describe how the pesticide is actually used and applied, including information on use and reapplication rates,frequency of use, and other use data relevant to exposure duringapplication.35Data required on dazomet.United States Environmental ProtectionAgency Washington, D.C. 20460LIST OF ALL REGISTRANTS SENT THIS DATA CALL-IN NOTICECo. Nr.Company NameAgent ForAddressCity & StateZipCase # and Name:2135,Dazomet, and saltsBASF CORPORATIONPO Box 13528 26 DAVIS DRIVERESEARCHTRIANGLE PARKNC2770935287969BUCKMAN LABORATORIES INC.1256 NORTH MCLEAN BLVDMEMPHISTN381081448CERTIS USA, LLC9145 GUILFORD ROAD, SUITE 175COLUMBIAMD2104670051VERICHEM, INC.3499 GRAND AVENUEPITTSBURGHPA1522567869KEMIRA CHEMICALS, INC,1950 VAUGHAN ROADKENNESAWGA301449386